{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:08:12Z","timestamp":1795140492788,"version":"4.10.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_200530"],"award-info":[{"award-number":["320030_200530"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003360","name":"Ligue Genevoise Contre le Cancer","doi-asserted-by":"publisher","award":["2204"],"award-info":[{"award-number":["2204"]}],"id":[{"id":"10.13039\/501100003360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023754","name":"Hjelt Foundations - Spina Bifida, Diabetes and Art | Bo and Kerstin Hjelt Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung f\u00fcr Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","award":["24C170"],"award-info":[{"award-number":["24C170"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), initiated by the pathological lipid accumulation within hepatocytes, can progress towards Metabolic dysfunction-Associated SteatoHepatitis (MASH) characterized by inflammation and fibrosis. Hepatic fibrosis is the strongest predictor of liver-related mortality, yet effective antifibrotic therapies remain limited, calling for identification of new molecular targets. Our previous work identified S100A10 as a MASLD promoter, suggesting that its association with AnnexinA2 (ANXA2) within the S100A10-ANXA2 heterotetramer (A2t) might promote hepatic fibrosis. Here, we inhibited A2t using its inhibitor, A2ti-1, in human hepatic stellate cells (LX-2) and in human multilineage liver organoids (HLOs) modeling MASLD. In LX-2, A2ti-1 reduced \u03b1-SMA protein levels and expression of profibrotic genes, indicating direct suppression of stellate cell activation. In HLOs, A2ti-1 significantly reduced fibrosis by lowering \u03b1-SMA levels, collagen deposition, and profibrotic gene expression, without altering steatosis. Mechanistically, A2ti-1 inhibited hepatic stellate cell activation through a SMAD-independent mechanism involving reduced STAT3 phosphorylation. These findings identify the S100A10-ANXA2 tetramer as a new regulator of hepatic stellate cells activation and highlight its inhibition as a promising antifibrotic strategy in MASH.<\/jats:p>","DOI":"10.1038\/s44321-026-00464-y","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:49:29Z","timestamp":1781095769000},"page":"2920-2945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids"],"prefix":"10.1038","volume":"18","author":[{"given":"Miranda","family":"T\u00fcrkal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Correia de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"El-Harane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gjorgjieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-1433","authenticated-orcid":false,"given":"Pierre","family":"Maechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-5680","authenticated-orcid":false,"given":"Etienne","family":"Delangre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"464_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-neuro-111020-090812","volume":"45","author":"MG Andrews","year":"2022","unstructured":"Andrews MG, Kriegstein AR (2022) Challenges of organoid research. Annu Rev Neurosci 45:23\u201339","journal-title":"Annu Rev Neurosci"},{"key":"464_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.867940","volume":"13","author":"JK Carter","year":"2022","unstructured":"Carter JK, Friedman SL (2022) Hepatic stellate cell-immune interactions in NASH. Front Endocrinol 13:867940","journal-title":"Front Endocrinol"},{"key":"464_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01236-6","volume":"8","author":"D Chakraborty","year":"2017","unstructured":"Chakraborty D, Sumova B, Mallano T, Chen CW, Distler A, Bergmann C, Ludolph I, Horch RE, Gelse K, Ramming A et al (2017) Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat Commun 8:1130","journal-title":"Nat Commun"},{"key":"464_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2025.11.003","volume":"284","author":"Z Chen","year":"2025","unstructured":"Chen Z, Ye L, Zhu M, Lin X, Wu J, Zhang X, Wang Y, Hong X, Li Z, Hu S et al (2025) Multi-omics analysis identifies S100a10\/Anxa2 complex within proximal tubule aggravates acute kidney injury through p-Stat3\/Spp1 signaling. Transl Res 284:57\u201368","journal-title":"Transl Res"},{"key":"464_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101126","volume":"6","author":"M Correia de Sousa","year":"2024","unstructured":"Correia de Sousa M, Delangre E, Berthou F, El Harane S, Maeder C, Fournier M, Krause KH, Gjorgjieva M, Foti M (2024) Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids. JHEP Rep 6:101126","journal-title":"JHEP Rep"},{"key":"464_CR6","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1128\/MCB.01192-08","volume":"28","author":"AC Daly","year":"2008","unstructured":"Daly AC, Randall RA, Hill CS (2008) Transforming growth factor beta-induced Smad1\/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28:6889\u20136902","journal-title":"Mol Cell Biol"},{"key":"464_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07940-2","volume":"16","author":"E Delangre","year":"2025","unstructured":"Delangre E, Correia de Sousa M, Turkal M, Gjorgjieva M, Chartier S, Arnoux G, Sobolewski C, Fournier M, Maeder C, Rubbia-Brandt L et al (2025) Comparative analysis of S100A10 and S100A11 in MASLD and hepatic cancer development revealed a tumor suppressive role for S100A10. Cell Death Dis 16:633","journal-title":"Cell Death Dis"},{"key":"464_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.14218\/JCTH.2014.00035","volume":"3","author":"B Delire","year":"2015","unstructured":"Delire B, Starkel P, Leclercq I (2015) Animal models for fibrotic liver diseases: what we have, what we need, and what is under development. J Clin Transl Hepatol 3:53\u201366","journal-title":"J Clin Transl Hepatol"},{"key":"464_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"ZQ Deng","year":"2024","unstructured":"Deng ZQ, Fan T, Xiao C, Tian H, Zheng YJ, Li CX, He J (2024) TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Tar 9:61","journal-title":"Signal Transduct Tar"},{"key":"464_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells8111419","volume":"8","author":"B Dewidar","year":"2019","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN (2019) TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells 8:1419","journal-title":"Cells"},{"key":"464_CR11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P et al (2017) Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 65:1557\u20131565","journal-title":"Hepatology"},{"key":"464_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/cells14151211","volume":"14","author":"S El Harane","year":"2025","unstructured":"El Harane S, Nazari B, El Harane N, Locatelli M, Zidi B, Durual S, Karmime A, Ravier F, Roux A, Stoppini L et al (2025) Generation of individualized, standardized, and electrically synchronized human midbrain organoids. Cells 14:1211","journal-title":"Cells"},{"key":"464_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03692-1","volume":"20","author":"Y Feng","year":"2022","unstructured":"Feng Y, Li W, Wang Z, Zhang R, Li Y, Zang L, Wang P, Li Z, Dong Y (2022) The p-STAT3\/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis. J Transl Med 20:497","journal-title":"J Transl Med"},{"key":"464_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semcdb.2019.11.013","volume":"101","author":"KW Finnson","year":"2020","unstructured":"Finnson KW, Almadani Y, Philip A (2020) Non-canonical (non-SMAD2\/3) TGF-beta signaling in fibrosis: mechanisms and targets. Semin Cell Dev Biol 101:115\u2013122","journal-title":"Semin Cell Dev Biol"},{"key":"464_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06313-9","volume":"23","author":"S Frendi","year":"2025","unstructured":"Frendi S, Chassac A, Veron K, Raffenne J, Nicolle R, Albuquerque M, Paradis V, Couvelard A, Cros J, Rebours V (2025) Protective role of oleic acid against palmitic acid-induced pancreatic fibrosis. J Transl Med 23:416","journal-title":"J Transl Med"},{"key":"464_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME et al (2024) A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med 390:497\u2013509","journal-title":"N Engl J Med"},{"key":"464_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6:425\u2013456","journal-title":"Annu Rev Pathol"},{"key":"464_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2023113898","volume":"42","author":"A Hess","year":"2023","unstructured":"Hess A, Gentile SD, Ben Saad A, Rahman RU, Habboub T, Pratt DS, Mullen AC (2023) Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. EMBO J 42:e113898","journal-title":"EMBO J"},{"key":"464_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27686-6","volume":"8","author":"Y Hong","year":"2018","unstructured":"Hong Y, Li S, Wang J, Li Y (2018) In vitro inhibition of hepatic stellate cell activation by the autophagy-related lipid droplet protein ATG2A. Sci Rep 8:9232","journal-title":"Sci Rep"},{"key":"464_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/cells9040964","volume":"9","author":"T Hurrell","year":"2020","unstructured":"Hurrell T, Kastrinou-Lampou V, Fardellas A, Hendriks DFG, Nordling A, Johansson I, Baze A, Parmentier C, Richert L, Ingelman-Sundberg M (2020) Human liver spheroids as a model to study aetiology and treatment of hepatic fibrosis. Cells 9:964","journal-title":"Cells"},{"key":"464_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","volume":"15","author":"S Kaur","year":"2023","unstructured":"Kaur S, Kidambi S, Ortega-Ribera M, Thuy LTT, Nieto N, Cogger VC, Xie WF, Tacke F, Gracia-Sancho J (2023) In vitro models for the study of liver biology and diseases: advances and limitations. Cell Mol Gastroenterol Hepatol 15:559\u2013571","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"464_CR22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jhep.2024.10.044","volume":"82","author":"HY Kim","year":"2025","unstructured":"Kim HY, Rosenthal SB, Liu X, Miciano C, Hou X, Miller M, Buchanan J, Poirion OB, Chilin-Fuentes D, Han C et al (2025) Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease. J Hepatol 82:882\u2013897","journal-title":"J Hepatol"},{"key":"464_CR23","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1101\/gad.193565.112","volume":"26","author":"Y Kim","year":"2012","unstructured":"Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J et al (2012) Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes Dev 26:1247\u20131262","journal-title":"Genes Dev"},{"key":"464_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto T (2005) Interleukin-6: from basic science to medicine\u201440 years in immunology. Annu Rev Immunol 23:1\u201321","journal-title":"Annu Rev Immunol"},{"key":"464_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/15548627.2024.2305063","volume":"20","author":"M Koh","year":"2024","unstructured":"Koh M, Lim H, Jin H, Kim M, Hong Y, Hwang YK, Woo Y, Kim ES, Kim SY, Kim KM et al (2024) ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells. Autophagy 20:659\u2013674","journal-title":"Autophagy"},{"key":"464_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651\u2013662","journal-title":"Nat Rev Mol Cell Biol"},{"key":"464_CR27","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.4049\/jimmunol.1401779","volume":"194","author":"C Li","year":"2015","unstructured":"Li C, Iness A, Yoon J, Grider JR, Murthy KS, Kellum JM, Kuemmerle JF (2015) Noncanonical STAT3 activation regulates excess TGF-beta1 and collagen I expression in muscle of stricturing Crohn\u2019s disease. J Immunol 194:3422\u20133431","journal-title":"J Immunol"},{"key":"464_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y (2024) Updated mechanisms of MASLD pathogenesis. Lipids Health Dis 23:117","journal-title":"Lipids Health Dis"},{"key":"464_CR29","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.3390\/ijms22136836","volume":"22","author":"HI Lim","year":"2021","unstructured":"Lim HI, Hajjar KA (2021) Annexin A2 in fibrinolysis, inflammation and fibrosis. Int J Mol Sci 22:6836","journal-title":"Int J Mol Sci"},{"key":"464_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.201004104","volume":"189","author":"M Linkert","year":"2010","unstructured":"Linkert M, Rueden CT, Allan C, Burel JM, Moore W, Patterson A, Loranger B, Moore J, Neves C, Macdonald D et al (2010) Metadata matters: access to image data in the real world. J Cell Biol 189:777\u2013782","journal-title":"J Cell Biol"},{"key":"464_CR31","doi-asserted-by":"publisher","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","volume":"288","author":"Y Liu","year":"2013","unstructured":"Liu Y, Liu H, Meyer C, Li J, Nadalin S, Konigsrainer A, Weng H, Dooley S, Ten Dijke P (2013) Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J Biol Chem 288:30708\u201330719","journal-title":"J Biol Chem"},{"key":"464_CR32","first-page":"34","volume":"10","author":"Y Ma","year":"2024","unstructured":"Ma Y, Harris J, Li P, Jiang C, Sun H, Cao H (2024) An integrative transcriptome subtraction strategy to identify human lncRNAs that specifically play a role in activation of human hepatic stellate cells. Noncoding RNA 10:34","journal-title":"Noncoding RNA"},{"key":"464_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06318-7","volume":"9","author":"SA MacParland","year":"2018","unstructured":"MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, Manuel J, Khuu N, Echeverri J, Linares I et al (2018) Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun 9:4383","journal-title":"Nat Commun"},{"key":"464_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, Iwaisako K, Liu X, Zhang M et al (2012) Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143:765\u2013776.e763","journal-title":"Gastroenterology"},{"key":"464_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH (2024) Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab 35:697\u2013707","journal-title":"Trends Endocrinol Metab"},{"key":"464_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jid.2010.255","volume":"131","author":"K Miyoshi","year":"2011","unstructured":"Miyoshi K, Takaishi M, Nakajima K, Ikeda M, Kanda T, Tarutani M, Iiyama T, Asao N, DiGiovanni J, Sano S (2011) Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 131:108\u2013117","journal-title":"J Invest Dermatol"},{"key":"464_CR37","doi-asserted-by":"publisher","first-page":"46122","DOI":"10.1074\/jbc.M406922200","volume":"279","author":"I Neeli","year":"2004","unstructured":"Neeli I, Liu ZM, Dronadula N, Ma ZA, Rao GN (2004) An essential role of the Jak-2\/STAT-3\/cytosolic phospholipase A axis in platelet-derived growth factor BB-induced vascular smooth muscle cell motility. J Biol Chem 279:46122\u201346128","journal-title":"J Biol Chem"},{"key":"464_CR38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/biom13101450","volume":"13","author":"GC Okura","year":"2023","unstructured":"Okura GC, Bharadwaj AG, Waisman DM (2023) Recent advances in molecular and cellular functions of S100A10. Biomolecules 13:1450","journal-title":"Biomolecules"},{"key":"464_CR39","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jhep.2024.01.002","volume":"80","author":"S Osonoi","year":"2024","unstructured":"Osonoi S, Takebe T (2024) Organoid-guided precision hepatology for metabolic liver disease. J Hepatol 80:805\u2013821","journal-title":"J Hepatol"},{"key":"464_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","volume":"30","author":"R Ouchi","year":"2019","unstructured":"Ouchi R, Togo S, Kimura M, Shinozawa T, Koido M, Koike H, Thompson W, Karns RA, Mayhew CN, McGrath PS et al (2019) Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab 30:374\u2013384.e376","journal-title":"Cell Metab"},{"key":"464_CR41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/glia.70018","volume":"73","author":"AP Patton","year":"2025","unstructured":"Patton AP, Krogager TP, Maywood ES, Smyllie NJ, Morris EL, Skehel M, Hastings MH (2025) Multi-Omic analysis reveals astrocytic Annexin-A2 as critical for network-level circadian timekeeping in the suprachiasmatic nucleus. Glia 73:1483\u20131501","journal-title":"Glia"},{"key":"464_CR42","doi-asserted-by":"publisher","first-page":"e31756","DOI":"10.7554\/eLife.31756","volume":"7","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran A, Vizan P, Das D, Chakravarty P, Vogt J, Rogers KW, Muller P, Hinck AP, Sapkota GP, Hill CS (2018) TGF-beta uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition. eLife 7:e31756","journal-title":"eLife"},{"key":"464_CR43","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/cmdc.201200107","volume":"7","author":"TR Reddy","year":"2012","unstructured":"Reddy TR, Li C, Fischer PM, Dekker LV (2012) Three-dimensional pharmacophore design and biochemical screening identifies substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction. ChemMedChem 7:1435\u20131446","journal-title":"ChemMedChem"},{"key":"464_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40425-018-0436-5","volume":"6","author":"MJ Reilley","year":"2018","unstructured":"Reilley MJ, McCoon P, Cook C, Lyne P, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N et al (2018) STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial. J Immunother Cancer 6:119","journal-title":"J Immunother Cancer"},{"key":"464_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29703-0","volume":"8","author":"MR Rocha","year":"2018","unstructured":"Rocha MR, Barcellos-de-Souza P, Sousa-Squiavinato ACM, Fernandes PV, de Oliveira IM, Boroni M, Morgado-Diaz JA (2018) Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-ss induced epithelial mesenchymal transition via Src\/ANXA2\/STAT3. Sci Rep 8:11285","journal-title":"Sci Rep"},{"key":"464_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13287-025-04139-2","volume":"16","author":"W Shao","year":"2025","unstructured":"Shao W, Xu H, Zeng K, Ye M, Pei R, Wang K (2025) Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling. Stem Cell Res Ther 16:27","journal-title":"Stem Cell Res Ther"},{"key":"464_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3350\/cmh.2020.0181","volume":"27","author":"G Soon","year":"2021","unstructured":"Soon G, Wee A (2021) Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: histological perspective. Clin Mol Hepatol 27:44\u201357","journal-title":"Clin Mol Hepatol"},{"key":"464_CR48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41592-025-02595-5","volume":"22","author":"C Stringer","year":"2025","unstructured":"Stringer C, Pachitariu M (2025) Cellpose3: one-click image restoration for improved cellular segmentation. Nat Methods 22:592\u2013599","journal-title":"Nat Methods"},{"key":"464_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M (2021) Cellpose: a generalist algorithm for cellular segmentation. Nat Methods 18:100\u2013106","journal-title":"Nat Methods"},{"key":"464_CR50","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"464_CR51","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1182\/blood-2009-06-226944","volume":"115","author":"JF Swisher","year":"2010","unstructured":"Swisher JF, Burton N, Bacot SM, Vogel SN, Feldman GM (2010) Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 115:549\u2013558","journal-title":"Blood"},{"key":"464_CR52","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","volume":"292","author":"LY Tang","year":"2017","unstructured":"Tang LY, Heller M, Meng Z, Yu LR, Tang Y, Zhou M, Zhang YE (2017) Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J Biol Chem 292:4302\u20134312","journal-title":"J Biol Chem"},{"key":"464_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.mcb.2020.03.009","volume":"159","author":"WL Thompson","year":"2020","unstructured":"Thompson WL, Takebe T (2020) Generation of multi-cellular human liver organoids from pluripotent stem cells. Methods Cell Biol 159:47\u201368","journal-title":"Methods Cell Biol"},{"key":"464_CR54","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/1078-0432.CCR-24-2920","volume":"31","author":"AM Tsimberidou","year":"2025","unstructured":"Tsimberidou AM, Vining DJ, Arora SP, de Achaval S, Larson J, Kauh J, Cartwright C, Avritscher R, Alibhai I, Tweardy DJ et al (2025) Phase I trial of TTI-101, a first-in-class oral inhibitor of STAT3, in patients with advanced solid tumors. Clin Cancer Res 31:965\u2013974","journal-title":"Clin Cancer Res"},{"key":"464_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166413","volume":"1868","author":"G Wang","year":"2022","unstructured":"Wang G, Duan J, Pu G, Ye C, Li Y, Xiu W, Xu J, Liu B, Zhu Y, Wang C (2022) The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression. Biochim Biophys Acta Mol Basis Dis 1868:166413","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"464_CR56","doi-asserted-by":"publisher","first-page":"30975","DOI":"10.18632\/oncotarget.5199","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Yuan J, Zhang J, Tian R, Ji W, Zhou Y, Yang Y, Song W, Zhang F, Niu R (2015) Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells. Oncotarget 6:30975\u201330992","journal-title":"Oncotarget"},{"key":"464_CR57","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1210\/clinem\/dgaf336","volume":"110","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou Y, Wang Z, Ni Y, Prud\u2019homme GJ, Wang Q (2025) Efficacy of GLP-1-based Therapies on metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis. J Clin Endocrinol Metab 110:2964\u20132979","journal-title":"J Clin Endocrinol Metab"},{"key":"464_CR58","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1053\/hupa.2000.8440","volume":"31","author":"K Washington","year":"2000","unstructured":"Washington K, Wright K, Shyr Y, Hunter EB, Olson S, Raiford DS (2000) Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. Hum Pathol 31:822\u2013828","journal-title":"Hum Pathol"},{"key":"464_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/wdev.86","volume":"2","author":"A Weiss","year":"2013","unstructured":"Weiss A, Attisano L (2013) The TGFbeta superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol 2:47\u201363","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"464_CR60","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01545-22","volume":"97","author":"M Weng","year":"2023","unstructured":"Weng M, Guo Z, Lu Q, Jin Q, Jiang Y, Wang F, Guo J, Xing G, Qiao S, Zhang G (2023) Pseudorabies virus regulates the extracellular translocation of Annexin A2 to promote its proliferation. J Virol 97:e0154522","journal-title":"J Virol"},{"key":"464_CR61","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/jac\/dkv045","volume":"70","author":"AW Woodham","year":"2015","unstructured":"Woodham AW, Taylor JR, Jimenez AI, Skeate JG, Schmidt T, Brand HE, Da Silva DM, Kast WM (2015) Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection. J Antimicrob Chemother 70:1686\u20131690","journal-title":"J Antimicrob Chemother"},{"key":"464_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13619-022-00148-1","volume":"12","author":"X Wu","year":"2023","unstructured":"Wu X, Jiang D, Yang Y, Li S, Ding Q (2023) Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. Cell Regen 12:6","journal-title":"Cell Regen"},{"key":"464_CR63","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/cpt.3606","volume":"117","author":"Y Wu","year":"2025","unstructured":"Wu Y, Dong P, Wu Q, Zhang Y, Xu G, Pan C, Tong H (2025) Insights into clinical trials for drugs targeting MASLD: progress, challenges, and future directions. Clin Pharm Ther 117:1614\u20131626","journal-title":"Clin Pharm Ther"},{"key":"464_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.dld.2017.02.013","volume":"49","author":"M Yang","year":"2017","unstructured":"Yang M, Wang C, Li S, Xv X, She S, Ran X, Li S, Hu H, Hu P, Zhang D et al (2017) Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion. Dig Liver Dis 49:780\u2013788","journal-title":"Dig Liver Dis"},{"key":"464_CR65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jcb.22529","volume":"110","author":"L Zhang","year":"2010","unstructured":"Zhang L, Peng X, Zhang Z, Feng Y, Jia X, Shi Y, Yang H, Zhang Z, Zhang X, Liu L et al (2010) Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis. J Cell Biochem 110:219\u2013228","journal-title":"J Cell Biochem"}],"updated-by":[{"DOI":"10.1038\/s44321-026-00512-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000}}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00464-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:03:01Z","timestamp":1787814181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00464-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,13]]}},"alternative-id":["464"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00464-y","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s44321-026-00512-7","URL":"https:\/\/doi.org\/10.1038\/s44321-026-00512-7","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}